Michael Scott

4.3k total citations
95 papers, 2.5k citations indexed

About

Michael Scott is a scholar working on Geriatrics and Gerontology, Applied Microbiology and Biotechnology and Epidemiology. According to data from OpenAlex, Michael Scott has authored 95 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Geriatrics and Gerontology, 19 papers in Applied Microbiology and Biotechnology and 16 papers in Epidemiology. Recurrent topics in Michael Scott's work include Pharmaceutical Practices and Patient Outcomes (28 papers), Antibiotic Use and Resistance (19 papers) and Health Systems, Economic Evaluations, Quality of Life (11 papers). Michael Scott is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (28 papers), Antibiotic Use and Resistance (19 papers) and Health Systems, Economic Evaluations, Quality of Life (11 papers). Michael Scott collaborates with scholars based in United Kingdom, Jordan and United States. Michael Scott's co-authors include Daniel F. Twomey, James C. McElnay, James C. McElnay, Mamoon A. Aldeyab, Mary P. Kearney, Claire Scullin, Fidelma A. Magee, Feras Darwish Elhajji, S. Ν. Eisenstadt and Yaser M. Alahmadi and has published in prestigious journals such as Nature, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Michael Scott

94 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Scott United Kingdom	27	662	513	444	314	309	95	2.5k
Veronika J. Wirtz United States	27	236 0.4×	386 0.8×	490 1.1×	66 0.2×	180 0.6×	162	3.0k
Ahmed Awaisu Qatar	32	854 1.3×	315 0.6×	429 1.0×	34 0.1×	304 1.0×	235	3.2k
Fahad Saleem Malaysia	33	653 1.0×	706 1.4×	580 1.3×	18 0.1×	247 0.8×	235	3.5k
Pauline Norris New Zealand	26	509 0.8×	346 0.7×	219 0.5×	21 0.1×	90 0.3×	133	2.1k
Albert I. Wertheimer United States	23	379 0.6×	145 0.3×	240 0.5×	28 0.1×	216 0.7×	174	2.0k
María Teresa Herdeiro Portugal	30	942 1.4×	963 1.9×	371 0.8×	8 0.0×	165 0.5×	152	3.6k
Shane Scahill New Zealand	22	548 0.8×	316 0.6×	134 0.3×	27 0.1×	95 0.3×	102	1.3k
Alian A. Alrasheedy Saudi Arabia	23	347 0.5×	363 0.7×	209 0.5×	22 0.1×	121 0.4×	76	1.4k
Carolyn Tarrant United Kingdom	33	119 0.2×	518 1.0×	301 0.7×	9 0.0×	174 0.6×	115	3.2k
Andy Gray South Africa	21	139 0.2×	107 0.2×	934 2.1×	37 0.1×	1.2k 3.9×	106	3.3k

Countries citing papers authored by Michael Scott

Since Specialization

Citations

This map shows the geographic impact of Michael Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Scott more than expected).

Fields of papers citing papers by Michael Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Scott. The network helps show where Michael Scott may publish in the future.

Co-authorship network of co-authors of Michael Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Scott. A scholar is included among the top collaborators of Michael Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Scott. Michael Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scott, Michael, et al.. (2024). The Medicines Optimisation Innovation Centre: a dedicated centre driving innovation in medicines optimisation-impact and sustainability. International Journal of Clinical Pharmacy. 46(5). 1001–1009. 2 indexed citations

Aldeyab, Mamoon A., William Crowe, Reema Karasneh, et al.. (2023). The impact of the COVID‐19 pandemic on antibiotic consumption and prevalence of pathogens in primary and secondary healthcare settings in Northern Ireland. British Journal of Clinical Pharmacology. 89(9). 2851–2866. 8 indexed citations

Harper, Roy, Michael Scott, Glenda Fleming, et al.. (2022). Adherence to metformin in adults with type 2 diabetes: a combined method approach. Journal of Pharmaceutical Policy and Practice. 15(1). 61–61. 4 indexed citations

Barron, John, et al.. (2021). Ensuring the quality and quantity of personal protective equipment (PPE) by enhancing the procurement process in Northern Ireland during the coronavirus disease 2019 pandemic: Challenges in the procurement process for PPE in NI. Journal of Patient Safety and Risk Management. 27(1). 42–49. 2 indexed citations

Scullin, Claire, Sonja Grigoleit, Constandinos X. Mavromoustakis, et al.. (2021). Shaping the Future of Digitally Enabled Health and Care. SHILAP Revista de lepidopterología. 9(1). 17–17. 8 indexed citations

Al‐Azzam, Sayer, Steven Williams, Wendy Wilson, et al.. (2021). General practitioner practice-based pharmacist input to medicines optimisation in the UK: pragmatic, multicenter, randomised, controlled trial. Journal of Pharmaceutical Policy and Practice. 14(1). 4–4. 19 indexed citations

Scott, Michael, et al.. (2020). Informing critical care drug requirements in response to the COVID-19 pandemic. European Journal of Hospital Pharmacy. 27(5). 263–266. 3 indexed citations

Scott, Michael, C. Hibberd, Ann Versporten, et al.. (2018). Longitudinal point prevalence survey of antibacterial use in Northern Ireland using the European Surveillance of Antimicrobial Consumption (ESAC) PPS and Global-PPS tool. Epidemiology and Infection. 146(8). 985–990. 19 indexed citations

Scullin, Claire, et al.. (2016). Nursing Home Outreach Clinics show an improvement in patient safety and reduction in hospital admissions in residents with chronic conditions. European Journal for Person Centered Healthcare. 4(4). 650–655. 5 indexed citations

10.

Aldeyab, Mamoon A., James C. McElnay, Michael Scott, Feras Darwish Elhajji, & Mary P. Kearney. (2013). Hospital antibiotic use and its relationship to age-adjusted comorbidity and alcohol-based hand rub consumption. Epidemiology and Infection. 142(2). 404–408. 10 indexed citations

11.

Aldeyab, Mamoon A., James C. McElnay, Michael Scott, et al.. (2013). A modified method for measuring antibiotic use in healthcare settings: implications for antibiotic stewardship and benchmarking. Journal of Antimicrobial Chemotherapy. 69(4). 1132–1141. 15 indexed citations

12.

Scullin, Claire, et al.. (2011). Comparison of tools for the assessment of inappropriate prescribing in hospitalized older people. Journal of Evaluation in Clinical Practice. 18(6). 1196–1202. 21 indexed citations

13.

Aldeyab, Mamoon A., Dominique L. Monnet, José-Marı́a López-Lozano, et al.. (2008). Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. Journal of Antimicrobial Chemotherapy. 62(3). 593–600. 116 indexed citations

14.

Scott, Michael, et al.. (2004). Evaluation of a hospital-based community liaison pharmacy service in Northern Ireland. Pharmacy World & Science. 26(2). 114–120. 101 indexed citations

15.

McElnay, James C., et al.. (2000). Use of a treatment protocol in the management of community-acquired lower respiratory tract infection. Journal of Antimicrobial Chemotherapy. 45(3). 387–394. 33 indexed citations

16.

McElnay, James C., et al.. (1995). Audit of antibiotic usage in a medium-sized general hospital over an 11-year period. Pharmacy World & Science. 17(6). 207–213. 14 indexed citations

17.

McElnay, James C., et al.. (1995). The effect of pH on the buccal and sublingual absorption of captopril. European Journal of Clinical Pharmacology. 48(5). 373–9. 19 indexed citations

18.

McElnay, James C., et al.. (1991). Sublingual captopril ? a pharmacokinetic and pharmacodynamic evaluation. European Journal of Clinical Pharmacology. 40(4). 393–398. 27 indexed citations

19.

Barton, Keith, et al.. (1989). Chlordiazepoxide Metabolite Accumulation in Liver Disease. PubMed. 4(1). 73–76. 5 indexed citations

20.

Scott, Michael & Daniel F. Twomey. (1988). The Long-Term Supply of Entrepreneurs: Students' Career Aspirations in Relation to Entrepreneurship. Journal of Small Business Management. 26(4). 5. 299 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact